Top Markets
Coin of the day
Purple Biotech Ltd. Purple Biotech Ltd.

Purple Biotech Ltd.

PPBT
Rang in Aktien #40643
Purple Biotech Ltd., a clinical-stage company, is focused on creating therapies... Purple Biotech Ltd., a clinical-stage company, is focused on creating therapies for cancer patients in the United States, specifically addressing challenges like tumor immune evasion and drug resistance. Its diverse oncology pipeline includes CM24, a humanized monoclonal antibody that targets and blocks carcinoembryonic antigen related cell adhesion molecule 1 (CEACAM1). Currently in Phase 2 clinical trials, CM24 is being investigated as a combination therapy with anti-PD-1 checkpoint inhibitors for treating pancreatic ductal adenocarcinoma. Another candidate is NT219, a small molecule compound in Phase 1/2 clinical trials, which functions by inhibiting insulin receptor substrate 1 and 2 (IRS1/2) and signal transducer and activator of transcription (STAT). This compound is being developed for recurrent and/or metastatic squamous cell carcinoma of the head and neck, or colorectal adenocarcinoma. Furthermore, IM1240, a multi-valent antibody designed to activate an anti-tumoral immune response against 5T4-positive tumors, is in its preclinical stage. The company has established significant collaborations, including an agreement with Bristol Myers Squibb Company for Phase 2 clinical trials to assess CM24 in combination with the PD-1 inhibitor nivolumab and chemotherapy, as well as a partnership with Mor Research Applications. Formerly known as Kitov Pharma Ltd., the company adopted the name Purple Biotech Ltd. in December 2020 and is headquartered in Rehovot, Israel.
Aktienkurs
$0.00323826
Zuletzt synchronisiert: 2026-08-12
Marktkapitalisierung
$104.81K
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
-70.42%
Land
IL
Handel Purple Biotech Ltd. (PPBT)

Kategorie

Preis PPBT mit Marktkapitalisierung von B
Purple Biotech Ltd. Purple Biotech Ltd.
PPBT
$0.00323826
Marktkapitalisierung von Purple Biotech Ltd.(PPBT)
Marktkapitalisierung: $104.81K
Mit Stand August 2026 hat Purple Biotech Ltd. eine Marktkapitalisierung von $104.81K. Das macht Purple Biotech Ltd. laut unseren Daten zum 40643rd wertvollsten Unternehmen der Welt nach Marktkapitalisierung. Die Marktkapitalisierung ist der Gesamtmarktwert aller ausstehenden Aktien eines börsennotierten Unternehmens und wird häufig verwendet, um den Unternehmenswert zu bestimmen.
Marktkapitalisierung von Purple Biotech Ltd. von 2002 bis 2026
PPBT im Vergleich zu den Top 5 der beliebtesten stocks
Preis für PPBT Vermögenswert B Marktkapitalisierung von B Ergebnisse
Purple Biotech Ltd. Purple Biotech Ltd.
$168,876 $104.81K
$5.466T +5,215,023,849.19%
Purple Biotech Ltd. Purple Biotech Ltd.
$137,731 $104.81K
$4.458T +4,253,248,315.50%
Purple Biotech Ltd. Purple Biotech Ltd.
$128,998 $104.81K
$4.175T +3,983,544,228.68%
Purple Biotech Ltd. Purple Biotech Ltd.
$113,349 $104.81K
$3.669T +3,500,297,589.27%
Purple Biotech Ltd. Purple Biotech Ltd.
$88,162.17 $104.81K
$2.853T +2,722,513,793.08%